NeoCore Technology Co., Ltd. (TPEX:4131)
30.00
-0.10 (-0.33%)
Nov 20, 2026, 11:29 AM CST
NeoCore Technology Market Cap
NeoCore Technology has a market cap or net worth of 1.2 billion as of November 20, 2026. It is the 31,898th most valuable company in the world and the 1,855th biggest in Taiwan. Its market cap has decreased by 6.66% in one year.
Market Cap
1.20B
Enterprise Value
1.31B
Revenue
271.62M
Global Rank
Country Rank
#1,855 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2004, NeoCore Technology's market cap has increased from 15.79M to 1.20B, an increase of 7,474.38%. That is a compound annual growth rate of 21.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.20B | -27.89% |
| Dec 31, 2025 | 1.66B | 31.25% |
| Dec 31, 2024 | 1.26B | 45.45% |
| Dec 29, 2023 | 869.00M | 123.11% |
| Dec 26, 2022 | 389.50M | 24.09% |
| Dec 28, 2021 | 313.90M | 1.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.42B |
| Anti-Microbial Savior BioteQ | 1.35B |
| GenMont Biotech Incorporation | 1.33B |
| Synbio Tech | 1.32B |
| Greenyn Biotechnology | 1.21B |
| MegaPro Biomedical | 1.19B |
| TaiRx | 1.19B |
| Advagene Biopharma | 1.18B |